Letters
21 June 2022

Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company

This article has been corrected.
VIEW CORRECTION
Publication: Annals of Internal Medicine
Volume 175, Number 7
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Supplemental Material

Supplement. Original Version (PDF)

References

1.
Mark Cuban Cost Plus Drug Company. Medications. Accessed at https://costplusdrugs.com/medications/ on 8 February 2022.
2.
Centers for Medicare & Medicaid Services. Medicare Part D spending by drug. Accessed at https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug on 18 February 2022.
3.
Trish EGascue LRibero Ret al. Comparison of spending on common generic drugs by Medicare vs Costco members. JAMA Intern Med. 2021;180:1414-1416. [PMID: 34228050]  doi: 10.1001/jamainternmed.2021.3366
4.
2021 Annual Report of the Board of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Accessed at www.cms.gov/files/document/2021-medicare-trustees-report.pdf on 18 February 2022.
5.
Sood N, Shih T, Van Nuys K, et al. The flow of money through the pharmaceutical distribution system. Accessed at https://healthpolicy.usc.edu/wp-content/uploads/2017/06/USC_Flow-of-MoneyWhitePaper_Final_Spreads.pdf on 18 February 2022.

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 175Number 7July 2022
Pages: 1053 - 1055

History

Published online: 21 June 2022
Published in issue: July 2022

Keywords

Authors

Affiliations

Hussain S. Lalani, MD, MPH https://orcid.org/0000-0002-5972-3997
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Aaron S. Kesselheim, MD, JD, MPH https://orcid.org/0000-0002-8867-2666
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Benjamin N. Rome, MD, MPH https://orcid.org/0000-0001-5776-3293
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
Financial Support: By Arnold Ventures (Drs. Kesselheim and Rome).
Reproducible Research Statement: Study protocol: Available from Dr. Lalani (e-mail, [email protected]). Statistical code: Not applicable. Data set: Available at https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug and https://costplusdrugs.com/medications/. This study was not submitted for institutional review board review because it used public, nonidentifiable data that does not constitute human subject research (45 CFR 46.102).
Corresponding Author: Hussain S. Lalani, MD, MPH, 1620 Tremont Street, Suite 3030, Boston, MA 02120; e-mail, [email protected].
Correction: This article was corrected on 8 July 2022 to reflect a revised analysis that corrected errors in matching on drug formulation and strength. Data in the text, table, and figure were updated.
This article was published at Annals.org on 21 June 2022.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Hussain S. Lalani, Aaron S. Kesselheim, Benjamin N. Rome. Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company. Ann Intern Med.2022;175:1053-1055. [Epub 21 June 2022]. doi:10.7326/M22-0756

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media